VOYAGER THERAPEUTICS INC. - COMMON STOCK

Voyager Therapeutics’ Novel Capsids Demonstrate Robust Delivery Across the Blood Brain Barrier, Widespread CNS Transduction in Non-Human Primates

11 5 2021 07:30:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates

10 5 2021 07:30:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2021 Annual Meeting

28 4 2021 08:00:02 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease

26 4 2021 08:00:01 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates

25 2 2021 16:01:01 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference

18 2 2021 16:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program

02 2 2021 16:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 1 2021 16:03:16 提供 Nasdaq GlobeNewswire